Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Neurology
•
Neuro-infectious disease
How do you approach management of HTLV1 myelopathy?
Related Questions
Do you repeat a lumbar puncture in a patient living with HIV diagnosed with and treated for neurosyphilis and if so, when?
Do you choose an antibiotic with CSF penetration, such as nafcillin over cefazolin, in the setting of MSSA endocarditis with septic emboli to the brain (assuming no concomitant meningitis or brain abscess)?
Would you consider AEDs in patients with recurrent TGA?
What is your preferred VMAT2 inhibitor to treat tardive dyskinesia? Tetrabenazine, valbenazine or deutetrabenazine?
What is your approach to the management of asymptomatic intracranial atherosclerosis discovered during the workup of an acute stroke?
What is your approach to management of a subtotally resected pineal parenchymal tumor of intermediate differentiation (CNS WHO grade 2)?
What are the main reasons that exercise trials have collectively failed to demonstrate sufficient evidence for disease modification in Parkinson's disease?
How would you determine the safety of anticoagulation in patients with evidence of cerebral microhemorrhages who present with acute stroke secondary to cardioembolism?
In what clinical situation do you use Botox in patients with increased salivation?
How would you evaluate and treat a disabling tongue tremor?
